Skip to main content
The Markets by Proactive
Go to Proactive UK
Proactive UK has moved. Growth stocks coverage continues on proactiveinvestors.com Go there →

Company

Gen-Probe

NASDAQ:GPRO

Gen-Probe Incorporated (Gen-Probe) is engaged in the development, manufacture and marketing of nucleic acid tests (NATs) used to diagnose human diseases and screening donated human blood. It also markets a range of products to detect infectious microorganisms, including those causing sexually transmitted diseases (STDs), tuberculosis, strep throat, and other infections. The Company categorizes its products into clinical diagnostic products and blood screening products.

41 stories · page 2 of 3

Media

Wall Street gains for 4th day on oil rebound; JPMorgan rises

Wall Street headed for its first four-day winning run since January, after a landmark nuclear deal between Tehran and six global powers left sanctions on Iran in place for now, while weaker-than-expected retail sales spurred bets on timing

By Proactive